AmoyDx® ALK and ROS1 Gene Fusions Detection Kit is a Real-Time PCR assay. The kit enables qualitative detection of up to 14 ALK gene fusions and 14 ROS1 gene fusions in human RNA extracted from FFPE tumor tissue. It is intended to aid in identifying ALK and ROS1 fusion status for patients with non-small cell lung cancer (NSCLC) who may be eligible for approved targeted therapies. The kit is for in vitro diagnostic use and intended for use by trained professionals in a laboratory environment.
One-step assay with simple operation
Low sample input requirement
Fast turnaround time of 1.5 hours
High sensitivity of 125-250 cp/rxn
Specifications
Shelf-life
12 months
Instrument
Stratagene Mx3000P™, ABI 7500, SLAN-96S
Tests/kit
8 (Pre-loaded)
Inquiry